| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/28/2008 | WO2008103042A1 Recombinant xrgd-enriched gelatins having high stability |
| 08/28/2008 | WO2008103041A1 Recombinant gelatins |
| 08/28/2008 | WO2008102923A1 Process for producing and purifying factor viii and its derivatives |
| 08/28/2008 | WO2008102912A1 Target protein and target gene for drug discovery, and screening method |
| 08/28/2008 | WO2008102782A1 Hair growth-inhibiting agent |
| 08/28/2008 | WO2008102557A1 Peptide vaccines for cancers expressing tumor-associated antigens |
| 08/28/2008 | WO2008102519A1 Gene involved in quorum-sensing system of acetic acid bacterium, acetic acid bacterium having modification of the gene and grown, and method for production of vinegar by using the acetic acid bacterium |
| 08/28/2008 | WO2008102008A1 Transglutaminase variants with improved specificity |
| 08/28/2008 | WO2008102007A1 Transglutaminase variants with improved specificity |
| 08/28/2008 | WO2008101850A1 Method of producing methionine in corynebacteria by over-expressing enzymes of the pentose phosphate pathway |
| 08/28/2008 | WO2008101847A1 Method for producing an antifungal peptide in a filamentous fungal host cell |
| 08/28/2008 | WO2008101680A1 Erythropoietin fusion protein |
| 08/28/2008 | WO2008101667A1 Method of purification of hydrophobic proteins |
| 08/28/2008 | WO2008101415A1 Recombinant chimeric protein of neutrophil inhibitory factor and hirugen and medicament composition thereof |
| 08/28/2008 | WO2008101406A1 Modified mutant collagenase and it's use in fat melting and in scar reduction |
| 08/28/2008 | WO2008101332A1 Triticum mosaic virus |
| 08/28/2008 | WO2008083169A3 Compositions and methods for the treatment of immunologic disorders |
| 08/28/2008 | WO2008080218A9 Methods of selecting and producing modified toxins, conjugates containing modified toxins and uses thereof |
| 08/28/2008 | WO2008060702A9 Replikin peptides and uses thereof |
| 08/28/2008 | WO2007081696A3 Treating androgen decline in aging male (adam)-associated conditions with sarms |
| 08/28/2008 | US20080209596 Plant sugar transport proteins |
| 08/28/2008 | US20080207886 Mammalian cytokine-like polypeptide-10 |
| 08/28/2008 | US20080207883 Platelet Derived Growth Factor (PDGF) Nucleic Acid Ligand Complexes |
| 08/28/2008 | US20080207880 Reduction of the Content of Protein Contaminents in Compositions Comprising a Vitamin K-Dependent Protein of Interest |
| 08/28/2008 | US20080207879 to enrich rFIX molecules which have been posttranslationally modified by sulfation and/or phosphorylation using anion exchange material |
| 08/28/2008 | US20080207878 Process for separating proteins fibrinogen, factor XIII and biological glue from a solubilized plasma fraction and for preparing lyophilised concentrates of said proteins |
| 08/28/2008 | US20080207877 Granulocyte cell stimulating factor (G-CSF), erythropoietin, interferon, and growth hormone |
| 08/28/2008 | US20080207875 Oligopeptide of given sequence, modified by cyclic topology; prevent infections and immune deficiencies |
| 08/28/2008 | US20080207615 Using allelic variations in epidermal growth factor gene as evaluative tool in predicting positive response to anticancer agents, therapy; administering gefitinib |
| 08/28/2008 | US20080207604 Dtection compound that moderated tau-tau protein association; Alzheimer's disease; administering methylene blue |
| 08/28/2008 | US20080207574 Withanolides, probes and binding targets and methods of use thereof |
| 08/28/2008 | US20080207562 Conjugates of Hydroxyalkyl Starch and Active Substance, Prepared by Chemical Ligation Via Thiazolidine |
| 08/28/2008 | US20080207552 Decoy compositions for treating and preventing brain diseases and disorders |
| 08/28/2008 | US20080207549 An antisense polynucleotide or short interfering RNA; diagnosis of proliferative diseases; targets for drug design; antiproliferative agents |
| 08/28/2008 | US20080207548 Immunogenic polynucleotides, expression vectors, antigen presenting host cells, diagnostic kits; cancer vaccines |
| 08/28/2008 | US20080207547 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080207543 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080207520 Tumor-associated Peptides Binding Promiscuously to Human Leukocyte Antigen (HLA) Class II Molecules |
| 08/28/2008 | US20080207518 Peptide analog with substitutions useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease; veterinary medicine, agriculture, aquaculture |
| 08/28/2008 | US20080207517 SELECTIVE INHIBITION OF NF-kappaB ACTIVIATION BY PEPTIDES DESIGNED TO DISRUPT NEMO OLIGOMERIZATION |
| 08/28/2008 | US20080207511 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 08/28/2008 | US20080207510 Modified vitamin k-dependent polypeptides |
| 08/28/2008 | US20080207508 Treatment of Fungal and/or Protist Infections |
| 08/28/2008 | US20080207507 Hypoglycemic agents; antidiabetic agents ; hypotensive agents; cardiovascular disorders; strokes; antiinflammatory agents; antiulcer agents; glucangon-like peptide |
| 08/28/2008 | US20080207506 Nucleic acid sequence coding Mammastatin; protein useful in diagnosis, therapy fo breast cancer ; antigrowth agents |
| 08/28/2008 | US20080207505 Diuretics; hypotensive agents; congestive heart failure; stimulate cyclic guanosine 3",5"-monophosphate |
| 08/28/2008 | US20080207504 SECRETED FRIZZLED RELATED PROTEIN, sFRP, FRAGMENTS AND METHODS OF USE THEREOF |
| 08/28/2008 | US20080207502 Anti-Angiogenic Peptides and Methods of Use Thereof |
| 08/28/2008 | US20080207501 Therapy for metabolism disorders, cardiovascular disorders, obesity, antidiabetic agents |
| 08/28/2008 | US20080207500 Propiomelanocortin and corticotropin releasing factor peptide; therapy for cancer, multiple sclerosis, nervous system disorders |
| 08/28/2008 | US20080207492 Crossing blood-brain barrier; central nervous system disorders; psychological disorders; behavioral disorders |
| 08/28/2008 | US20080207490 Glucose Uptake Modulator and Method for Treating Diabetes or Diabetic Complications |
| 08/28/2008 | US20080207487 Manufacturing process for the production of polypeptides expressed in insect cell-lines |
| 08/28/2008 | US20080207486 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080207485 Major histocompatibility complex with peptide binding grooves; controlling oligomerization |
| 08/28/2008 | US20080207484 Polypeptides; hybrid nucleic acids; anticancer agents; central nervous system disorders |
| 08/28/2008 | US20080207449 Polypeptides; antisense nucleic acids; gene expression vectors that have been inserted: transgenic plants; agriculture; diagnosis; screening; therapy |
| 08/28/2008 | US20080206885 Environmentally sensitive fluorophores |
| 08/28/2008 | US20080206873 Recombinant pre-integration complex (rPIC) for use as gene transfer tool in genetic engineering |
| 08/28/2008 | US20080206863 embryonic stem cell having been genetically engineered with DNA which encodes MyoD, which promotes differentiation of said embryonic stem cell into a muscle cell |
| 08/28/2008 | US20080206815 Polypeptides having cellulolytic enhancing activity and nucleic acids encoding same |
| 08/28/2008 | US20080206813 Means and methods for regulating gene expression |
| 08/28/2008 | US20080206812 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles |
| 08/28/2008 | US20080206809 Peptide tags for the expression and purification of bioactive peptides |
| 08/28/2008 | US20080206808 Galactosyl nucleotide sugar |
| 08/28/2008 | US20080206785 Using voltage sensitive dyes to identifying modulators of G-protein sensory signaling; immunoassay; customizing taste of foods and/or medicines |
| 08/28/2008 | US20080206750 Novel fetal genes |
| 08/28/2008 | US20080206747 Methods, Kits and Compositions Pertaining to Combination Oligomers and Libraries for Their Preparation |
| 08/28/2008 | US20080206743 Rapid and Specific Detection of Enterobacter Sakazakii |
| 08/28/2008 | US20080206742 Fragments of INI/hSNF5 that comprise the Rpt1 domain, inhibit HIV-1 replication, particle production, and cell-to-cell spread; antisense nucleotides; vectors; drug screening for anti-HIV drugs |
| 08/28/2008 | US20080206283 Vaccine Against Sars |
| 08/28/2008 | US20080206282 Chimeric lyssavirus nucleic acids and polypeptides |
| 08/28/2008 | US20080206277 Isolated Nucleic Acid Molecule Encoding a Neurotrophic Growth Factor |
| 08/28/2008 | US20080206271 Contains a binding ligand, a Pseudomonas exotoxin A translocation domain II, an antigenic moiety, and a carboxyl terminal moiety which binds to the endoplasmic reticulum of the target T-cells, B-cells, dendritic cells, monocytes, or macrophages; inoculation |
| 08/28/2008 | US20080206269 stimulate the resuscitation of bacteria after true dormancy; cognate receptors, convertases, respective genes and inhibitors or mimetics |
| 08/28/2008 | US20080206268 HA-1 epitopes and uses thereof |
| 08/28/2008 | US20080206267 Inactivation Of Genes Of The Mep Pathway |
| 08/28/2008 | US20080206266 Carbohydrate ligand that specifically binds to a leczyme; nucleic acid sequence encoding a nonclassical MHC class I heavy chain; ability to associate with a beta 2 microglobulin; major histocompatibility complex transplantation molecules |
| 08/28/2008 | US20080206264 when bound by a highly potent human neutralizing monoclonal antibody specific for a V3 conformational epitope; immunogens for inducing broadly-neutralizing antibodies against HIV-1 as well as antagonists for inhibiting the binding of HIV-1 to the relevant co-receptors |
| 08/28/2008 | US20080206261 administering RegIII protein or Ins2 protein; expression of the IBD marker was decreased |
| 08/28/2008 | US20080206260 Chimeric Tbp-toxin proteins as mucosal adjuvants for vaccination against neisseriae |
| 08/28/2008 | US20080206256 Treatments for cancer |
| 08/28/2008 | US20080206255 Antibody cancer immunotherapy |
| 08/28/2008 | US20080206252 Novel Polypeptides, and Nucleic Acids Encoding the Same |
| 08/28/2008 | US20080206250 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206249 comprise one or more breast tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides |
| 08/28/2008 | US20080206247 Glycoprotein VI fusion proteins |
| 08/28/2008 | US20080206246 Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 08/28/2008 | US20080206245 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206244 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206238 Angiogenesis-Inhibiting Chimeric Protein and the Use |
| 08/28/2008 | US20080206234 Compositions and methods for the therapy and diagnosis of breast cancer |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | US20080206210 gene therapy by intrathymic administration; lentiviral vectors |
| 08/28/2008 | US20080206190 Glycosylated IL-7, Preparation And Uses |
| 08/28/2008 | US20080206189 Using water-soluble polymer conjugated interleukin-18 as therapeutic in treatment and prevention of cell proliferative disorders |
| 08/28/2008 | US20080206182 biocompatible hydroxyalkyl starch, dextran or polyethylene glycol polymers functionalized by an aminooxy group; improved circulatory life time in vivo; reduced antigenicity and immunogenicity of the proteins; therapeutic proteins such as EPO, G-CSF, Factor VII, Factor IX, IFN beta, AT III, A1AT, Factor V |
| 08/28/2008 | US20080206142 Use to treat dyslipidemic disorders, stroke and myocardial infarction; detecting plaque in vessels using the labeled peptides; peptides with apolipoprotein A-I (apoA-I) domains |
| 08/28/2008 | US20080206141 Optical Imaging Contrast Agents |